| Financial Ratios | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
| Return on Equity | 42.758 | - | - | - |
| Net Profit Margin | -221.832 | -653.178 | 195.809 | -43.072 |
| Debt to Asset Ratio | 154.319 | - | - | - |
| Cash Ratio | 50.591 | - | - | - |
| Quick Ratio | 129.49 | - | - | - |
| Current Ratio | 151.641 | - | - | - |
Adaptimmune Therapeutics PLC (ADAP)
Adaptimmune Therapeutics PLC (ADAP)